Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Management Change

Kwality Pharmaceuticals has regularized the appointment of Mr. Swanith Kapoor as Independent Director and reappointed Mr. Aditya Arora as Whole Time Director for five years.

Kwality Pharmaceuticals Earnings Call Transcript: Key Takeaways

Kwality Pharma Q1FY27 con-call highlights revision of FY27 revenue target to ₹700Cr+ with 26-27% EBITDA margins, driven by niche injectable registrations in LATAM and MENA regions.

Call

Guides 30% growth

Kwality Pharmaceuticals Investor Presentation: Key Takeaways

Kwality Pharma reported strong Q1FY27 performance with revenue up 45.7% YoY. Management raised FY27 revenue guidance to INR 700+ Cr and improved margin outlook.

Call

Guides 39% growth

Kwality Pharmaceuticals Q1 FY27 Results: Net Profit ₹25.6 Cr, Up 115.1% YoY

Kwality Pharmaceuticals Ltd reported revenue from operations of ₹162.4 Cr (+45.7% YoY) and net profit of ₹25.6 Cr (+115.1% YoY) for Q1 FY27.

Key figure

Net profit ₹25.6 Cr · +115.1% YoY

Kwality Pharmaceuticals Earnings Call: Key Takeaways

Kwality Pharmaceuticals delivered a landmark FY26 with 36% revenue growth and 69% PAT growth, driven by higher-margin oncology products and improved operational efficiencies.

Kwality Pharmaceuticals Earnings Call: Key Takeaways

Kwality Pharmaceuticals delivered strong FY26 performance with ₹503 Cr revenue and ₹67 Cr PAT, driven by regulated market expansion and 4/5 EU-GMP approved units.

Kwality Pharmaceuticals Q4 FY26 Results: Net Profit ₹25.3 Cr, Up 74.5% YoY

Kwality Pharmaceuticals Ltd reported revenue from operations of ₹157.1 Cr (+35.8% YoY) and net profit of ₹25.3 Cr (+74.5% YoY) for Q4 FY26.

Key figure

Net profit ₹25.3 Cr · +74.5% YoY